CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 67 filers reported holding CULLINAN ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,929 | -44.8% | 5,959 | -34.4% | 0.00% | – |
| Q2 2023 | $97,679 | +105.4% | 9,078 | +95.3% | 0.00% | – |
| Q1 2023 | $47,549 | +4654.9% | 4,648 | +6446.5% | 0.00% | – |
| Q3 2022 | $1,000 | -75.0% | 71 | -79.4% | 0.00% | – |
| Q2 2022 | $4,000 | -96.6% | 345 | -96.9% | 0.00% | – |
| Q1 2022 | $116,000 | -61.5% | 11,087 | -43.2% | 0.00% | – |
| Q4 2021 | $301,000 | +30000.0% | 19,509 | +34737.5% | 0.00% | – |
| Q3 2021 | $1,000 | -99.5% | 56 | -99.3% | 0.00% | – |
| Q2 2021 | $204,000 | +19.3% | 7,923 | +93.5% | 0.00% | – |
| Q1 2021 | $171,000 | – | 4,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |